The perinatal period is associated with an increased risk of severe mental disorders. We
summarise the evidence regarding the epidemiology, risk factors, and treatment of severe …

BACKGROUND: Although many women treated with psychotropic medication become
pregnant, no psychotropic medication has been licensed for use in pregnancy. This leaves …

Decisions about the use of psychotropic medication in pregnancy are an ongoing challenge
for clinicians and women with mental health problems, owing to the uncertainties around …

Background: The incidence of pregnancy-associated cancer (PAC) is expected to increase
as more women delay childbearing until later ages. However, information on frequency and …

Objective To evaluate maternal medical and perinatal outcomes associated with
antipsychotic drug use in pregnancy. Design High dimensional propensity score (HDPS) …

Objective: Second-generation antipsychotics are used to treat a spectrum of psychiatric
illnesses in reproductive-age women. The National Pregnancy Registry for Atypical …

OBJECTIVE: To characterize the 20 most common prescription medications and the 10 most
common prescription medications classified in the former US Food and Drug Administration …

This study aims to explore practice, use, and risk of electroconvulsive therapy (ECT) in
pregnancy. A systematic search was undertaken in the databases Medline, Embase …

OBJECTIVE: Antipsychotic medications are used by increasing numbers of women of
reproductive age. The safety of these medications during pregnancy has not been well …

Objective: Some atypical antipsychotics are associated with metabolic side effects, which
are risk factors for gestational diabetes. The authors examined the risk of developing …